uracil has been researched along with Coronary Disease in 3 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| " All participants had a documented history of coronary heart disease or high cardiovascular risk at screening and received aspirin (acetylsalicylic acid) 100 mg daily throughout the trial." | 9.51 | Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomi ( Gao, B; Gao, W; Ji, Q; Wan, H; Xu, F; Zhang, X; Zhou, R, 2022) |
| " All participants had a documented history of coronary heart disease or high cardiovascular risk at screening and received aspirin (acetylsalicylic acid) 100 mg daily throughout the trial." | 5.51 | Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomi ( Gao, B; Gao, W; Ji, Q; Wan, H; Xu, F; Zhang, X; Zhou, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, B | 1 |
| Gao, W | 1 |
| Wan, H | 1 |
| Xu, F | 1 |
| Zhou, R | 1 |
| Zhang, X | 1 |
| Ji, Q | 1 |
| Leshchinskiĭ, LA | 1 |
| Shinkareva, IA | 1 |
| Stupnitskiĭ, AA | 1 |
| Golikov, BM | 1 |
| Apanasenko, AA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Alogliptin vs. Acarbose in Chinese T2DM Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive: A Multicenter, Randomized, Open Label, Prospective Study[NCT03794336] | Phase 4 | 1,293 participants (Actual) | Interventional | 2019-06-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for uracil and Coronary Disease
| Article | Year |
|---|---|
Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomi
Topics: Acarbose; Adult; Aspirin; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Glycated | 2022 |
2 other studies available for uracil and Coronary Disease
| Article | Year |
|---|---|
[Use of steroid and nonsteroid anabolites in ischemic heart disease].
Topics: Anabolic Agents; Coronary Disease; Humans; Methandrostenolone; Potassium Magnesium Aspartate; Uracil | 1976 |
[Mechanism of changes in the duration of the phase of asynchronous contraction in patients with hypertensive disease and atherosclerosis].
Topics: Adult; Aged; Antihypertensive Agents; Coronary Disease; Female; Guanethidine; Heart; Humans; Hyperte | 1971 |